Development of a High‐Throughput Microarray Platform for Rapid, Low‐Cost Expanded Carrier Screening

Authors:

Abstract
Objective: To develop a customized expanded carrier screening (ECS) solution for 8271 variants of 265 genes. Based on a microarray platform, this solution demonstrates comparable accuracy to next‐generation sequencing (NGS) platform; however, it has a lower cost, a faster speed, and a simplified data—analysis process. Method: A dedicated panel composed of 8271 variants of 265 high—priority genes was developed for custom microarray fabrication. To test the performance of the custom microarray, we selected 1051 blood samples from an NGS‐based ECS project to conduct a blind test. The evaluation indicators include sensitivity, specificity and positive predictive value. Results: 582 variants were identified in 69 genes. The concordance between the microarray platform and NGS platform results reaches 99.5%. The microarray demonstrated high sensitivity (99.8%) and specificity (99.8%), showing excellent performance in both positive and negative samples. The microarray platform reduces testing cycles to 3–4 days and lowers costs by 94%–96%. Conclusion: This study confirms that microarray‐based carrier screening is a reliable, cost‐effective, and timely alternative to NGS, and it is especially suitable for large‐scale population screening.
Funding Information
  • National Key Research and Development Program of China (2024YFC2707000)
  • National Key Research and Development Program of China (2021YFC1005301)

This publication has 18 references indexed in Scilit: